REAL-WORLD TREATMENT ADHERENCE AND OVERALL SURVIVAL IN CANCER PATIENTS RECEIVING PEMBROLIZUMAB THROUGH A PATIENT ASSISTANCE PROGRAM AT MILITARY HOSPITAL 175. YHCĐ 2026, 67 (Số CĐ12- Bệnh viện Ung bướu Nghệ An). https://doi.org/10.52163/yhc.v67iCD12.6167.